...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studies
【24h】

Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studies

机译:开启1,5-二芳基吡咯衍生物对抗耐药Eskape细菌的活性:结构 - 活性关系和行动模式

获取原文
获取原文并翻译 | 示例

摘要

Antibiotic resistance represents a major threat worldwide. Gram-positive and Gram-negative opportunistic pathogens are becoming resistant to all known drugs mainly because of the overuse and misuse of these medications and the lack of new antibiotic development by the pharmaceutical industry. There is an urgent need to discover structurally innovative antibacterial agents for which no pre-existing resistance is known. This work describes the identification, synthesis and biological evaluation of a novel series of 1,5-diphenylpyrrole compounds active against a panel of ESKAPE bacteria. The new compounds show high activity against both wild type and drug-resistant Gram + ve and Gram-ve pathogens at concentrations similar or lower than levofloxacin. Microbiology studies revealed that the plausible target of the pyrrole derivatives is the bacterial DNA gyrase, with the pyrrole derivatives displaying similar inhibitory activity to levofloxacin against the wild type enzyme and retaining activity against the fluoroquinolone-resistant enzyme. (C) 2019 Elsevier Masson SAS. All rights reserved.
机译:抗生素抗性代表全球主要威胁。克阳性和革兰氏阴性机会主义病原体对所有已知的药物都具有抗性,主要是因为过度使用和滥用这些药物和制药行业缺乏新的抗生素发育。迫切需要发现结构性创新的抗菌剂,没有已知预先存在的抗性。该作品描述了对eSkape细菌面板的新型1,5-二苯基吡咯化合物的鉴定,合成和生物学评价。新化合物对野生型和耐药克+ vE和克葡萄葡萄病原体的浓度相似或低于左氧氟沙星。微生物学研究表明,吡咯衍生物的可合理靶标是细菌DNA乙酸酶,吡咯衍生物显示与氟醛氧氟辛蛋白相对于野生型酶的类似抑制活性,并保持对氟喹诺酮抗性酶的保持活性。 (c)2019年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号